References
- Drwal-Klein LA, O'Donovan CA. Varicella in pediatric patients. Ann Pharmacother 1993; 27(7–8):938–49
- White CJ, Kuter BJ, Ngai A, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992; 11(1): 19–23
- Gershon AA. Varicella vaccine. Isr J Med Sci 1994; 30(5–6):482–4
- Gershon AA, LaRussa P, Hardy I, et al. Varicella vaccine: the American experience. J Infect Dis 1992; 166(Suppl 1):S63–8
- Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271(5):375–81
- Balcarek KB, Bagley MR, Pass RF, et al. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children. J Infect Dis 1995; 171(Suppl 1):S70–2
- Sandman L, Davidson M, Krugman S. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals. J Infect Dis 1995; 171(Suppl 1):S50–2
- Nalin DR, Kuter BJ, Brown L, et al. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. J Hepatol 1993; 18(Suppl 2):S51–5
- Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994; 271(17):1328–34
- Clemens R, Safary A, Hepburn A, et al. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995; 171(Suppl 1):S44–9
- Centers for Disease Control and Prevention. Hepatitis A among persons with hemophilia who received clotting factor concentrate: United States, September-December 1995. MMWR 1996; 45(2):29–32
- Centers for Disease Control and Prevention. Licensure of inactivated hepatitis A vaccine and recommendations for use among international travelers. MMWR 1995: 44(29): 559–60
- La Brooy JT. Typhoid in 1993. Med J Aust 1993; 159(9):598–601
- Shepard DS, Walsh JA, Kleinau E, et al. Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach. Vaccine 1995; 13(8):707–14
- Centers for Disease Control and Prevention. Typhoid immunization. MMWR 1994; 43(RR-14):1–7
- Plotkin SA, Bouveret-Le Cam N. A new typhoid vaccine composed of the vi capsular polysaccharide. Arch Intern Med 1995; 155:2293–9
- Hall CB. A single shot at Salmonella typhi: a new typhoid vaccine with pediatric advantages. Pediatrics 1995; 96(2 Pt 1):348–50
- Simanjuntak CH, Paleologo FP, Punjabi NH, et al. Oral immunisation against typhoid fiver in Indonesia with Ty21a vaccine. Lancet 1991; 338(8774):1055–9
- Levine MM, Ferreccio C, Black RE, et al. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1987; 1(8541):1049–52
- Cumberland NS, St Clair Roberts J, Arnold WS, et al. Typhoid Vi: a less reactogenic vaccine. J Int Med Res 1992; 20(3):247–53